Exploring Galantamine Modifications for Alzheimer's Treatment

Galantamine, known for its role in managing brain disorders, has been modified to create potential drugs for Alzheimer's disease. Scientists designed and synthesized a variety of galantamine analogues, one of which, named C2, showed great promise. By adding a benzylpyridine ring to galantamine's hydroxyl group, C2 became a powerful dual inhibitor of cholinesterase. It outperformed galantamine, showing excellent inhibitory activities against both human cholinesterases.

In lab tests, C2 protected brain cells from damage caused by hydrogen peroxide (H₂O₂) and reduced the production of harmful reactive oxygen species (ROS). It also proved safe in animal tests. When given to animals with memory problems caused by Aβ₁₄₂ or scopolamine, C2 improved their cognitive function and memory significantly. These results suggest that C2 could be an effective treatment for Alzheimer's. More research is needed, but the initial findings are very encouraging.

Actions